A placebo-controlled, double-blind, randomized, multicenter study of ramipril 5 and 10 mg capsules and insulin infusion in subjects with unstable coronary syndromes.
Latest Information Update: 03 Nov 2021
At a glance
- Drugs Ramipril (Primary) ; Insulin
- Indications Acute coronary syndromes; Myocardial infarction
- Focus Therapeutic Use
- Acronyms FOCUS
- Sponsors Sanofi
- 13 Sep 2006 New trial record.